Skip navigation | ||
|
||
Medical Encyclopedia |
|
Other encyclopedia topics: | A-Ag Ah-Ap Aq-Az B-Bk Bl-Bz C-Cg Ch-Co Cp-Cz D-Di Dj-Dz E-Ep Eq-Ez F G H-Hf Hg-Hz I-In Io-Iz J K L-Ln Lo-Lz M-Mf Mg-Mz N O P-Pl Pm-Pz Q R S-Sh Si-Sp Sq-Sz T-Tn To-Tz U V W X Y Z 0-9 |
Contents of this page: | |
|
Definition Return to top
Chlamydia is a sexually transmitted disease caused by the bacteria Chlamydia trachomatis.
Causes Return to top
Chlamydia infection is caused by the organism Chlamydia trachomatis. It is the most common sexually transmitted disease in the United States. Sexually active individuals and individuals with multiple partners are at highest risk.
Chlamydia may be acquired jointly with gonorrhea and/or syphilis, so individuals with one sexually transmitted disease must be screened for other sexually transmitted diseases as well. Untreated chlamydia can lead to pelvic infection and infertility.
In men, chlamydia may produce symptoms similar to those of gonorrhea (discharge from penis or rectum, burning on urination or defecation), and can also cause epididymitis and orchitis. However, up to 25% of infected men may have no symptoms.
Chlamydia (female): only approximately 30% of women will have symptoms due to chlamydia -- hence screening sexually active women for chlamydia is necessary to diagnose and treat asymptomatic women in order to decrease the risk of developing complications. Women who do have symptoms may note vaginal discharge, burning on urination, or abdominal pain.
Untreated infection may lead to pelvic inflammatory disease (PID), which can cause scarring of the fallopian tubes and result in infertility. Tubal scarring also increases the likelihood of an ectopic pregnancy (tubal pregnancy).
If a women is infected with chlamydia while pregnant, the infection can cause premature labor and delivery. In addition, the infant may develop chlamydial conjunctivitis (eye infection) and chlamydial pneumonia.
Symptoms Return to top
MALE
FEMALE
Exams and Tests Return to top
The diagnosis of chlamydia infection involves sampling of the urethral discharge in males or cervical secretions in females. If an individual engages in anal sexual contact, samples from the rectum may also be needed. The sample is sent for a fluorescent or monoclonal antibody test, DNA probe test or cell culture. Some of these tests may also be performed on urine samples.
Treatment Return to top
The mainstay of therapy for chlamydia includes appropriate antibiotic treatment -- these include: tetracyclines, azithromycin or erythromycin. All sexual contacts should be screened for chlamydia.
Sexual partners must be treated to prevent passing the infection back and forth. There is no significant immunity following the infection and a person may become repeatedly infected.
A follow-up evaluation may be done in 4 weeks to determine if the infection has been cured.
Outlook (Prognosis) Return to top
Early antibiotic treatment is extremely successful and may prevent the development of long-term complications. Untreated infection, however, may lead to PID, scarring and ultimately infertility.
Possible Complications Return to top
When to Contact a Medical Professional Return to top
Call your health care provider if you have any of the symptoms associated with chlamydial infection.
Because a significant proportion of individuals with chlamydia may not have any symptoms, sexually active adults (in particular women with new or multiple partners) should be screened periodically for chlamydia.
Prevention Return to top
Safe sexual practices and consistent condom use are important prevention measures to help decrease infection with chlamydia. In addition, sexually active individuals (in particular women with new or multiple sexual partners) should be periodically screened for chlamydia.
Update Date: 6/20/2007 Updated by: Arnold L. Lentnek, MD, Division of Infectious Disease, Kennestone Hospital, Marietta, GA. Review provided by VeriMed Healthcare Network.
Home | Health Topics | Drugs & Supplements | Encyclopedia | Dictionary | News | Directories | Other Resources | |
Copyright | Privacy | Accessibility | Quality Guidelines U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894 National Institutes of Health | Department of Health & Human Services |
Page last updated: 02 January 2008 |